# OnCo record moma-341 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/moma-341/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "moma-341" ;
  schema:name "MOMA-341"@en ;
  schema:description "MOMA-341 is an experimental small molecule from MOMA Therapeutics, in phase 1 trials for MSI-high / dMMR solid tumours, colorectal cancer and gastric cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/moma-341/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://momatx.com/posts/moma-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-for-moma-341/>, <https://momatx.com/posts/moma-therapeutics-announces-initiation-of-phase-1-clinical-trial-for-moma-313/>, <https://clinicaltrials.gov/search?intr=MOMA-341> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral, covalent)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/endometrial/> ;
  onco:targets <https://onco.cc/targets/wrn/> ;
  onco:companies <https://onco.cc/companies/moma-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06974110/> .